References
- Geneva: World Health Organization. WHO Guidelines. Approved by the Guidelines Review Committee. WHO recommendations for prevention and treatment of Preclampsia and Eclampsia. 2011
- Pilalis A, Souka AP, Antsaklis P, Daskalakis G, Papantoniou N, Mesogitis S, et al. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11–14 weeks gestation. Ultrasound Obstet Gynecol. 2007;29(2):135–40.
- LA Ong CT, Spencer K, Munim S, Nicolaides KH. First-trimester maternal serum free beta-human chorionic gonadotropin and pregnancy associated plasma protein-A as predictors of pregnancy complications. Int J Obstetrics and Gynaecology. 2000;107:1265–70.
- Kane Costa FS, Brennecke S. First Trimester Biomarkers in the Prediction of Later Pregnancy Complications
- Poon LC, Nicolaides KH. Early prediction of preeclampsia. Obstet Gynecol Int. 2014;2014:297.
- Zhong Y, Zhu F, Ding Y. Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis. BMC Pregnancy and Childbirth 2015;15:191.
- Bonno M, Oxvig C, Kephart GM, et al., Localization of pregnancy-associated plasma protein-a and colocalization of pregnancy-associated plasma protein-a messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta. Lab Invest 1994;71(4):560–566.
- Lawrence JB, Oxvig C, OvergaardM T, et al., The insulinlike growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proceedings of the National Academy of Sciences of the United States of America 1999;96(6):3149–3153.
- Zhong Y, Tuuli M, Odibo AO. First-trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction. Prenat Diagn. 2010;30(4):293–308.
- Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 2008;51(4):970–5.
- Papageorghiou AT, Yu CKH, Cicero S, Bower S, Nicolaides KH, Second-trimester uterine artery Doppler screening in unselected populations: a review. J Maternal-Fetal Neonatal Med 2002;12(2):78–88.
- Martin AM, Bindra R, Curcio P, Cicero S, Nicolaides KH. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11–14 weeks of gestation. Ultrasound in Obstetrics and Gynecology 2001;18(6):583–586.
- Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia. Ultrasound in Obstetrics and Gynecology 2007: 30(5):742–749.
- Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B. The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstetrics and Gynecology 2003;189(4):1173–1177.
- Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. Br J Obstetrics and Gynaecology 2006;113(5);580–589.
- Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 1988 Apr;158(4);892–898.